John P. Saharek
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John P. Saharek
John P. Saharek is recorded as CEO at Harrow, Inc. (HROW). Harrow, Inc. reported in an 8-K filed January 3, 2024 that John P. Saharek was appointed President and Chief Executive Officer of the Company's ImprimisRx division, effective January 2, 2024. The proxy statement of Harrow, Inc. reports total compensation of $727,421 for John P. Saharek in fiscal 2025, including a base salary of $475,614. Disclosed compensation is on record for 7 fiscal years.
“Effective January 2, 2024, Harrow, Inc. (the “Company”) appointed John P. Saharek as the President and Chief Executive Officer of the Company’s ImprimisRx division, in addition to his current role as Chief Commercial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Harrow, Inc. (HROW)
Proxy statement
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harrow, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis W. Mullery CEO
- Frank Mullery CEO
- Mark L. Baum CEO
- Robert J. Kammer Chairman
- Andrew Boll CFO
- Andrew R. Boll CFO
- Randall E. Pollard Chief Accounting Officer
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Lauren P. Silvernail Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Harrow, Inc. (HROW) | Former President and Chief Executive Officer, ImprimisRx Division | $475,614 | $727,421 |
| 2024 | Harrow, Inc. (HROW) | Former President and Chief Executive Officer, ImprimisRx Division | $463,431 | $743,467 |
| 2023 | Harrow, Inc. (HROW) | Chief Commercial Officer; Chief Executive Officer and President, ImprimisRx | $431,463 | $5,815,154 |
| 2022 | Harrow, Inc. (HROW) | Chief Commercial Officer; Chief Executive Officer and President, ImprimisRx | $378,955 | $656,887 |
| 2021 | Harrow, Inc. (HROW) | Chief Commercial Officer and President, ImprimisRx | $347,308 | $2,676,858 |
| 2020 | Harrow, Inc. (HROW) | President, ImprimisRx | $316,731 | $533,538 |
| 2019 | Harrow, Inc. (HROW) | President, ImprimisRx | $290,122 | $963,798 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.